Senior Director, Compliance, Europe

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

RevMed is seeking an experienced compliance leader in Europe. As a key member of the Legal and Compliance function this is an excellent opportunity to lead a team and support the launch of new RevMed therapies and the Company’s rapid business growth in Europe. The position will contribute to the development and implementation of organizational strategies, policies and practices and work with...